---
title: "Serina Therapeutics (SER.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/SER.US/norm.md"
symbol: "SER.US"
name: "Serina Therapeutics"
parent: "https://longbridge.com/zh-CN/quote/SER.US.md"
datetime: "2026-05-21T21:02:35.400Z"
locales:
  - [en](https://longbridge.com/en/quote/SER.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SER.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SER.US/norm.md)
---

# Serina Therapeutics (SER.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.5800 | -0.3174 | -0.4532 | -0.6600 | -0.4933 |
| ROE | -715.65% | 330.81% | 593.35% | 3654.84% | -1644.06% |
| 营业收入 | - | 0.0000 | - | 130000.00 | - |
| 净利润 | -6.90M | -3.37M | -4.69M | -6.57M | -4.81M |
| 营业利润 | -6.28M | -6.21M | -6.39M | -5.57M | -5.86M |
| 毛利率 | - | - | - | -2324.62% | - |
| 净利率 | - | - | - | -4960.00% | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 27.30M | 6.95M | 12.41M | 8.94M | 6.73M |
| 权益乘数 | 1.55 | -187.86 | 7.79 | 5.43 | 4.32 |
| 每股净资产 | 0.8516 | -0.4622 | -0.3016 | -0.3093 | 0.1713 |
| 资产周转率 | 0.0076 | 0.0190 | 0.0117 | 0.0132 | 0.0058 |
| 现金及短投 | 24.53M | 3.06M | 8.62M | 6.04M | 4.27M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 800000.00 | 842000.00 | 892000.00 | 950000.00 | 977000.00 |
| 净债务 | -21.36M | 267000.00 | -5.23M | -5.68M | -3.85M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -4.57M | -6.03M | -3.85M | -3.75M | -4.32M |
| 投资现金流 | -25000.00 | 0.0000 | -13000.00 | -46000.00 | - |
| 融资现金流 | 26.06M | 481000.00 | 6.44M | 5.57M | 4.92M |
| 自由现金流 | 102000.00 | -5.25M | -1.75M | -1.86M | -2.18M |
| 现金流充裕率 | -18272.00% | - | -29615.38% | -8152.17% | - |
| 举债与偿债 | - | 0.0000 | 4.91M | - | - |
| 资本支出 | -25000.00 | 0.0000 | -13000.00 | -46000.00 | - |